WESTBURY, N.Y., March 27, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months and year ended December 31, 2013. “Our equipment segment, which includes EECP® and Biox™ products, showed momentum in the last quarter of 2013 with equipment sales up by 26% for the quarter, and, as...
Read More

WESTBURY, N.Y., March 21, 2014 /PRNewswire/ — Vasomedical, Inc. (OTC BB: VASO) announced today that it will release its financial results for the three months ended and year ended December 31, 2013 on Thursday, March 27, 2014. The Company will host a conference call on Thursday, March 27th at 10:00 a.m. ET featuring remarks by...
Read More

WESTBURY, N.Y., March 17, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, including EECP® Therapy systems, the gold standard of ECP therapy, today announced that its wholly owned subsidiary Biox Instruments Co. Ltd., based in Wuxi, China, has received approval...
Read More

WESTBURY... N.Y.... Jan. 6... 2014 /PRNewswire/ — Vasomedical... Inc. (“Vasomedical”) (OTCBB: VASO)... a diversified medical technology company specializing in the design... manufacture and sale of medical devices including EECP® (Enhanced External Counterpulsation) Therapy systems... the gold standard of ECP therapy... announced today that the U.S. Food and Drug Administration (FDA)... Department of Health and Human Services...
Read More

WESTBURY, N.Y., Nov. 14, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months ended September 30, 2013. “We are pleased to report that during the third quarter of 2013 the Company recorded significant growth in both the Equipment segment and the Sales Representation segment.  Total equipment sales...
Read More